Due to the COVID-19 pandemic, the ACP office is now closed as our staff work remotely. Click here to see how this impacts our programs and operations.

Important safety bulletin from ISMP Canada

May 29, 2019

Lack of standardized documentation contributes to a mix-up between methadone and buprenorphine-naloxone.

A recent mix-up between methadone and buprenorphine-naloxone for a patient’s opioid agonist therapy led to an important safety bulletin from the Institute for Safe Medication Practices (ISMP) Canada. ISMP recommends pharmacies use standardized documentation templates to avoid such mistakes.

For more, visit the ISMP Canada website.

← Previous ArticleNext Article →